Evidence map›Paper›PMID 31263500›Full record

ArticleObstetrics and gynecology international2019

Challenges in Managing Patients with Hereditary Cancer at Gynecological Services.

Mako Ueda, Hiroshi Tsubamoto, Mina Kashima-Morii, Yoshitaka Torii, Mariko Kamihigashi, Yu Wakimoto, Nami Nakagomi, Tomoko Hashimoto-Tamaoki, Hideaki Sawai, Hiroaki Shibahara

Abstract read
In one paragraph

Article in Obstetrics and gynecology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mako UedaDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Hiroshi TsubamotoDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.ORCID 0000-0002-6135-6313
Mina Kashima-MoriiDepartment of Clinical Genetics, Hyogo College of Medicine, Nishinomiya, Japan.
Yoshitaka ToriiDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Japan.
Mariko KamihigashiDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Yu WakimotoDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.ORCID 0000-0001-8989-6998
Nami NakagomiDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Japan.
Tomoko Hashimoto-TamaokiDepartment of Clinical Genetics, Hyogo College of Medicine, Nishinomiya, Japan.
Hideaki SawaiDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Hiroaki ShibaharaDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo reveal current problems and challenges faced by our gynecologic services department in managing patients with hereditary cancers.

methodsWe collected clinical data of patients with hereditary cancers, identified via genetic testing (or clinically diagnosed in cases of Cowden syndrome or Peutz-Jeghers syndrome), and treated in our gynecological department from 2012 to 2018.

resultsFifteen patients had hereditary breast and ovarian cancer (HBOC), 6 had Lynch syndrome, 2 had Cowden syndrome, and 2 had Peutz-Jeghers syndrome. Five patients diagnosed with HBOC were younger than 40 years at diagnosis. Risk-reducing salpingo-oophorectomy (RRSO) was performed on 1 patient with a

conclusionManaging patients with hereditary cancer, positive or false-positive ascites cytology discovered during RRSO, and desired preservation of fertility is highly challenging.

Identifiers

PMID31263500
PMCPMC6556775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.